Literature DB >> 16127257

Ruptured vertebral artery dissecting aneurysm followed by spontaneous acute occlusion and early recanalization: case report.

Hidehiko Endo1, Yasunari Otawara, Kuniaki Ogasawara, Akira Ogawa, Shin-ichi Nakamura.   

Abstract

A 47-year-old man presented with a ruptured vertebral artery dissecting aneurysm manifesting as subarachnoid hemorrhage followed by acute occlusion and early recanalization of the affected artery. Cerebral angiography 2 hours after the onset of the symptom showed pearl-and-string sign in the right vertebral artery. Serial angiography showed that the affected artery was occluded at 12 hours but was recanalized on the 4th day. The dissecting aneurysm was resected with side-to-side anastomosis between the bilateral posterior inferior cerebellar arteries. Postoperative cerebral angiography demonstrated disappearance of the lesion and patency of the right posterior inferior cerebellar artery via the anastomosis. Histological examination of the lesion showed hematoma between the media and adventitia, disrupting the internal elastica and intima. Acute occlusion and early recanalization of the affected artery may occur in ruptured vertebral artery dissecting aneurysms. Serial neurological and neuroradiological examinations are essential to decide the timing and method of treatment.

Entities:  

Mesh:

Year:  2005        PMID: 16127257     DOI: 10.2176/nmc.45.400

Source DB:  PubMed          Journal:  Neurol Med Chir (Tokyo)        ISSN: 0470-8105            Impact factor:   1.742


  2 in total

1.  Recanalisation of spontaneously occluded vertebral artery dissection after subarachnoid haemorrhage.

Authors:  Takenori Akiyama; Satoshi Onozuka; Takashi Horiguchi; Kazunari Yoshida
Journal:  Neurosurg Rev       Date:  2012-08-11       Impact factor: 3.042

Review 2.  Therapeutic Progress in Treating Vertebral Dissecting Aneurysms Involving the Posterior Inferior Cerebellar Artery.

Authors:  Lei Shi; Kan Xu; Xiaofeng Sun; Jinlu Yu
Journal:  Int J Med Sci       Date:  2016-06-30       Impact factor: 3.738

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.